Scientists use CRISPR to shrink goldenberry plants for easier farming

Researchers at Cold Spring Harbor Laboratory have employed CRISPR gene-editing to create more compact goldenberry plants, reducing their size by about 35 percent to simplify cultivation. This innovation targets the fruit's unruly growth while preserving its nutritious, sweet-tart flavor. The approach aims to enable large-scale farming and enhance crop resilience amid climate challenges.

Goldenberries, a small fruit related to tomatoes and primarily grown in South America, have gained attention for their nutritional value and balanced taste. However, their bushy, sprawling nature has long hindered efficient harvesting, as farmers rely on largely undomesticated varieties.

A team led by postdoc Miguel Santo Domingo Martinez in Zachary Lippman's lab at Cold Spring Harbor Laboratory addressed this by applying CRISPR to edit genes previously targeted in tomatoes and groundcherries. The modifications resulted in plants roughly a third shorter, allowing denser planting and easier management in agricultural settings.

"These massive, sprawling plants in an agricultural setting are cumbersome for harvest," explained greenhouse technician Blaine Fitzgerald.

To maintain flavor, the researchers sampled fruits directly from fields, tasting hundreds to select the best performers. After several generations of selective breeding, they developed two new lines combining compact stature with robust taste, though the fruits are slightly smaller.

The work builds on millennia of traditional selective breeding that shaped modern crops but accelerates the process for undomesticated species. "By using CRISPR, you open up paths to new and more resilient food options," Fitzgerald said. "In an era of climate change and increasing population size, bringing innovation to agricultural production is going to be a huge path forward."

Future efforts could focus on boosting fruit size or resistance to diseases and drought, according to Santo Domingo: "We can use these modern tools to domesticate undomesticated crops."

Regulatory approval remains the next hurdle before seeds reach growers for broader production. The findings appear in the journal PLANTS, PEOPLE, PLANET.

Related Articles

Illustration of CRISPR epigenome editing tool removing red methyl tags from a holographic DNA model to activate fetal globin genes, with sickle cell blood cells normalizing, in a modern research lab.
Image generated by AI

CRISPR-based epigenome editing switches genes on by removing methyl tags, without cutting DNA

Reported by AI Image generated by AI Fact checked

Researchers at UNSW Sydney and St. Jude Children’s Research Hospital report a CRISPR-derived “epigenome editing” approach that turns genes on by removing DNA methylation marks rather than cutting DNA. In cell-based experiments, they show that promoter methylation can directly—and reversibly—silence fetal globin genes, a finding they say helps settle a long-running debate about whether methylation is causal or merely correlated with gene shutdown. The work points to a potential path toward safer therapies for sickle cell disease by reactivating fetal hemoglobin without creating DNA breaks.

Researchers in Israel have used CRISPR gene editing to deactivate a gene that produces bitter chemicals in grapefruit, potentially making the fruit more appealing to consumers. This innovation could expand the market for citrus and combat the devastating citrus greening disease by enabling cold-hardy, edible varieties. The approach aims to shift citrus farming to temperate regions like northern Europe.

Reported by AI

Health economics specialist Martin Morgenstern stated in an interview that genetic editing will transform medical treatments in the coming decades. According to him, technologies like CRISPR will allow altering specific genes to combat conditions like high cholesterol. This approach promises to be more precise than traditional medications, though it carries inherent risks.

An extract from Nitraria roborowskii, a desert shrub used in traditional Chinese medicine, improved insulin sensitivity and metabolic markers in diabetic mice by reactivating the PI3K/AKT pathway, according to a peer‑reviewed study in the Chinese Journal of Modern Applied Pharmacy and a summary posted on ScienceDaily.

Reported by AI

Scientists at UBC Okanagan have identified the enzymes plants use to produce mitraphylline, a rare compound with potential anti-cancer properties. This breakthrough solves a long-standing mystery and paves the way for sustainable production of such molecules. The discovery highlights plants' untapped potential in medicine.

A virus damaging cotton crops has been present in American fields since at least 2006, far earlier than previously thought. New research reveals that cotton leafroll dwarf virus, officially detected in 2017, spread undetected across key growing regions. The findings underscore the value of reanalyzing old data to uncover hidden agricultural threats.

Reported by AI Fact checked

Penn State researchers report a bacterial defense that repurposes dormant viral DNA: a recombinase enzyme called PinQ flips a stretch of genome to produce protective proteins that block infection, work described in Nucleic Acids Research.

 

 

 

This website uses cookies

We use cookies for analytics to improve our site. Read our privacy policy for more information.
Decline